Ann: Notification of upcoming expiry of Unlisted Options, page-26

First 26 Last

Share
Profile

Follow
Owl vs Fox

6,434 Posts.

5274

21/03/24

11:40

Post #: 72991982
Share

Originally posted by singhgu: ↑

My God....

Level of dumbness on this forum is scary....And someone even put a vote up for "Great Analysis"..

For all who think the company would have been trading higher post the results....

Know that there is no certainty when it comes to Biotech sector...All LT holders know that market has never priced this company fairly so there is absolutely no certainty the SP would have definitely moved up enough...We have seen multiple examples of companies ann. positive results for the SP to run high at the open and finish same at the end of the day.....so those orders you see after results ann. isn't a reflection of where SP was going to do...

On top...Most raises are done at a discount of 15-20% on WAPP anyway even for companies in much stronger position (thats just the nature of current market, though there are always exceptions).

Rather than wasting 2-3 month with hope of appreciation in SP, having the money now strengthen our hands on partnering discussions happening right now.

Do you guys really think the companies who put non binding offers are not keeping eyes on other assets in the same category? Timing is everything in deal making...Last thing you want to do if you are Dimerix is keep SH happy for their pips needs and be ready now and in better negotiating position for the deals you potentially have on the table..

The only critical points that will for sure drive the SP is US and China deal...Period.

Expand

And…the rest of Asia & the world. We could literally get a T/O offer from a BP, potentially not even more licencing deals. People shouldn’t forget the efficacy in early basket trials in CKD of multiple pathologies.

Have a good day folks.

DXB Price at posting: 33.0¢ Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply